NCT06443528

Brief Summary

This study aimed to fill this knowledge gap and designed a multicentre cohort study to verify the hypothesis that LUS has good reliability to predict BPD in China and to compare the predictive value of LUS and clinical models for the development of BPD at different time points in infants born before and after 28 weeks.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,620

participants targeted

Target at P75+ for all trials

Timeline
42mo left

Started Sep 2024

Longer than P75 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress33%
Sep 2024Sep 2029

First Submitted

Initial submission to the registry

May 30, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 5, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2027

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2029

Last Updated

June 27, 2024

Status Verified

March 1, 2024

Enrollment Period

3.1 years

First QC Date

May 30, 2024

Last Update Submit

June 26, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • bronchopulmonary dysplasia

    The outcome was bronchopulmonary dysplasia, as defined by the NIH in 2001 and Jensen in 2019:(1)no BPD as not receiving supplemental oxygen (O2) for 28 days or at 36 weeks;mild BPD as receiving O2 for greater than or equal to 28 days but not at 36 weeks; moderate BPD as receiving O2 for greater than or equal to28 days plus treatment with less than 30% O2 at 36 weeks; and severe BPD as receiving O2 for greater than or equal to 28 days plus greater than or equal to 30% O2 or positive pressure at 36 weeks;(2)No BPD was defined as breathing in room air at 36 weeks' PMA; grade 1 BPD as receipt of nasal cannula ≤2L/min (or hood O2); grade 2 BPD as nasal cannula \>2L/min, nasal continuous positive airway pressure (CPAP), or nasal intermittent positive pressure ventilation;and grade 3 BPD as invasive mechanical ventilation

    2024.06.01-2027.06.30

Study Arms (1)

Preterm infants with GA <32 weeks

Diagnostic Test: lung ultrasound

Interventions

lung ultrasoundDIAGNOSTIC_TEST

All enrolled infants underwent LUS examination performed by two ultrasound physicians. Monitoring included a complete lung scan in the first 24 hours of life (T0) and at day 3 (T1). All neonates underwent weekly ultrasound examinations until 36 weeks postmenstrual age (T2, T3…), so that the T2 scan was carried out at the end of the first week of life. LUS was performed according to a standardized protocol \[13\] when the neonate was in a quiet state, during routine clinical care to minimise discomfort. All ultrasound images and videos were digitally recorded, anonymised, and reviewed by a senior independent ultrasonographer blinded to patients' clinical information. Each lung was divided into three regions according to the anterior and posterior axillary lines and the mammary line. The regions were the upper-anterior, lower-anterior, and latera regions.

Preterm infants with GA <32 weeks

Eligibility Criteria

Age0 Weeks - 32 Weeks
Sexall
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Infants who meet all of the inclusion and exclusion criteria will be included

You may qualify if:

  • Preterm infants with GA \<32 weeks.
  • Infants with enrollment within 24 hours from birth
  • Parental written consent is obtained.

You may not qualify if:

  • Complex congenital malformations or chromosomal abnormalities
  • Congenital lung diseases or congenital heart defects
  • Infants with enrollment after 24 hours from birth

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Bronchopulmonary Dysplasia

Condition Hierarchy (Ancestors)

Ventilator-Induced Lung InjuryLung InjuryLung DiseasesRespiratory Tract DiseasesInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 30, 2024

First Posted

June 5, 2024

Study Start

September 1, 2024

Primary Completion (Estimated)

September 30, 2027

Study Completion (Estimated)

September 30, 2029

Last Updated

June 27, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share